Citrullinated peptides in the diagnosis of rheumatoid arthritis

Current Topics in Medicinal Chemistry

Volumn 13, Issue 6, 2013, Pages 743-751

  Gómara, María J ^a   Haro, Isabel ^a  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

Author keywords

Chimeric peptides; Citrullinated peptides; Cyclic peptides; Diagnosis; Rheumatoid arthritis

Indexed keywords

ARGININE; AUTOANTIBODY; BIOLOGICAL MARKER; CITRULLINE; CYCLOPEPTIDE; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN 2; FIBRIN; FILAGGRIN; RHEUMATOID FACTOR; SYNTHETIC PEPTIDE; VIMENTIN;

ARTICLE; CD4+ T LYMPHOCYTE; CYCLIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIMERIZATION; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; IMMOBILIZATION; MICROARRAY ANALYSIS; PEPTIDE SYNTHESIS; PROTEIN PROCESSING; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

ARTHRITIS, RHEUMATOID; HUMANS; PEPTIDES, CYCLIC;

EID: 84878785660     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611313060007     Document Type: Article

References (57)

1. Muller, S. Synthetic peptides as tools for diagnosis and therapeutic strategies to treat systemic lupus erythematous. Autoimmun. Rev., 2012, 11(11), 799-800.
2. Doyle, H. A.; Mamula, M. J. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol., 2001, 22(8), 443-449.
3. Nuti, F.; Peroni, E.; Real-Fernandez, F.; Bonache, M. A.; Chevalier-Isaad, A.; Chelli, M.; Lubin-Germain, N.; Uziel, J.; Rovero, P.; Lolli, F.; Papini, A. M. Posttranslationally Modified Peptides Efficiently Mimicking Neoantigen: A Challenge for Theragnostics of Autoimmune Diseases. Biopolymers, 2010, 94(6), 791-799.
4. Papini, A. M. The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases. J. Pept. Sci., 2009, 15(10), 621-628.
5. Lolli, F.; Mulinacci, B.; Carotenuto, A.; Bonetti, B.; Sabatino, G.; Mazzanti, B.; D'Ursi, A. M.; Novellino, E.; Pazzagli, M.; Lovato, L.; Alcaro, M. C.; Peroni, E.; Pozo-Carrero, M. C.; Nuti, F.; Battistini, L.; Borsellino, G.; Chelli, M.; Rovero, P.; Papini, A. M. An Nglucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. P. Natl. Acad. Sci. USA, 2005, 102(29), 10273-10278.
6. Schellekens, G. A.; Visser, H.; de Jong, B. A. W.; Van den Hoogen, F. H. J.; Hazes, J. M. W.; Breedveld, F. C.; van Venrooij, W. J. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum., 2000, 43(1), 155-163.
7. van Venrooij, W. J.; Hazes, J. M.; Visser, H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth. J. Med., 2002, 60(10), 383-388.
8. Barakat, S.; Meyer, O.; Torterotot, F.; Youinou, P.; Briand, J. P.; Kahn, M. F.; Muller, S. IgG Antibodies from Patients with Primary Sjogrens-Syndrome and Systemic Lupus-Erythematosus Recognize Different Epitopes in 60-Kd Ssa/Ro Protein. Clin. Exp. Immunol., 1992, 89(1), 38-45.
9. Tuaillon, N.; Andre, C.; Briand, J. P.; Penner, E.; Muller, S. A Lipoyl Synthetic Octadecapeptide of Dihydrolipoamide Acetyltransferase Specifically Recognized by Anti-M2 Autoantibodies in Primary Biliary-Cirrhosis. J. Immunol., 1992, 148(2), 445-450.
10. Muller, S.; Monneaux, F.; Schall, N.; Rashkov, R. K.; Oparanov, B. A.; Wiesel, P.; Geiger, J. M.; Zimmer, R. Spliceosomal Peptide P140 for Immunotherapy of Systemic Lupus Erythematosus Results of an Early Phase II Clinical Trial. Arthritis Rheum., 2008, 58(12), 3873-3883.
11. Gomara, M. J.; Haro, I. Synthetic peptides for the immunodiagnosis of human diseases. Curr. Med. Chem., 2007, 14(5), 531-546.
12. Gomara, M.J.; Haro, I. Peptide-based diagnostic assays. In Medicinal Protein Engineering. Khudyakov, Y. E. Ed.; CRC Press: Florida, 2008; pp 333-352.
13. Haro, I.; Gomara, M. J.; Perez, M. L.; Vinas, O.; Ercilla, G.; Gomez-Puerta, J. A.; Sanmarti, R. Antibodies against beta-fibrin synthetic peptides: A study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients. Eur. J. Med. Chem., 2011, 46(4), 1095-1102.
14. White, C. J.; Yudin, A. K. Contemporary strategies for peptide macrocyclization. Nat. Chem., 2011, 3(7), 509-524.
15. Tam, J. P.; Wong, C. T. T. Chemical Synthesis of Circular Proteins. J. Biol. Chem., 2012, 287(32), 27020-27025.
16. Dawson, P. E.; Muir, T. W.; Clarklewis, I.; Kent, S. B. H. Synthesis of Proteins by Native Chemical Ligation. Science, 1994, 266(5186), 776-779.
17. Clark, R. J.; Craik, D. J. Native Chemical Ligation Applied to the Synthesis and Bioengineering of Circular Peptides and Proteins. Biopolymers, 2010, 94(4), 414-422.
18. Perez, T.; Ercilla, G.; Chan, W. C.; Haro, I. Antigenicity of chimeric and cyclic synthetic peptides based on nonstructural proteins of GBV-C/HGV. J. Pept. Sci., 2006, 12(4), 267-278.
19. Njouom, R.; Nerrienet, E.; Budkowska, A.; Maillard, P.; Rousset, D.; Kalinina, O.; Mavromara, P. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa. J. Clin. Virol., 2010, 49(1), 61-64.
20. Pandiaraja, P.; Arunkumar, C.; Hoti, S. L.; Rao, D. N.; Kaliraj, P. Evaluation of synthetic peptides of WbSXP-1 for the diagnosis of human lymphatic filariasis. Diagn. Micr. Infec. Dis., 2010, 68(4), 410-415.
21. Gomara, M. J.; Fernandez, L.; Perez, T.; Ercilla, G.; Haro, I. Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection. Anal. Biochem., 2010, 396(1), 51-58.
22. Kasai, T.; Tokuda, T.; Taylor, M.; Nakagawa, M.; Allsop, D. Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for A beta oligomers. Biochem. Bioph. Res. Co., 2012, 422(3), 375-380.
23. Smolen, J.S. Autoantibodies in rheumatoid arthritis. In: Manual of Biological Markers of Disease. Maini, RN. and van Venrooij, W. J. Eds.; Kluwer Academic Publishers: Dordrecht, The Netherlands, 1993; pp 4-8.
24. Aletaha, D.; Neogi, T.; Silman, A. J.; Funovits, J.; Felson, D. T.; Bingham, C. O.; Birnbaum, N. S.; Burmester, G. R.; Bykerk, V. P.; Cohen, M. D.; Combe, B.; Costenbader, K. H.; Dougados, M.; Emery, P.; Ferraccioli, G.; Hazes, J. M. W.; Hobbs, K.; Huizinga, T. W. J.; Kavanaugh, A.; Kay, J.; Kvien, T. K.; Laing, T.; Mease, P.; Menard, H. A.; Moreland, L. W.; Naden, R. L.; Pincus, T.; Smolen, J. S.; Stanislawska-Biernat, E.; Symmons, D.; Tak, P. P.; Upchurch, K. S.; Vencovsky, J.; Wolfe, F.; Hawker, G. 2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum., 2010, 62(9), 2569-2581.
25. Forslind, K.; Ahlmen, M.; Eberhardt, K.; Hafstrom, I.; Svensson, B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann. Rheum. Dis., 2004, 63(9), 1090-1095.
26. Meyer, O.; Labarre, C.; Dougados, M.; Goupille, P.; Cantagrel, A.; Dubois, A.; Nicaise-Roland, P.; Sibilia, J.; Combe, B. Anticitrullinated protein/pepticle antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann. Rheum. Dis., 2003, 62(2), 120-126.
27. Foulquier, C.; Sebbag, M.; Clavel, C.; Chapuy-Regaud, S.; Al Badine, R.; Mechin, M. C.; Vincent, C.; Nachat, R.; Yamada, M.; Takahara, H.; Simon, M.; Guerrin, M.; Serre, G. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis Synovium in close association with tissue inflammation. Arthritis Rheum., 2007, 56(11), 3541-3553.
28. Schellekens, G. A.; de Jong, B. A. W.; Van den Hoogen, F. H. J.; van de Putte, L. B. A.; van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest., 1998, 101(1), 273-281.
29. Schellekens, G. A.; Visser, H.; de Jong, B. A. W.; Van den Hoogen, F. H. J.; Hazes, J. M. W.; Breedveld, F. C.; van Venrooij, W. J. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum., 2000, 43(1), 155-163.
30. Vossenaar, E. R.; van Venrooij, W. J. Anti-CCP antibodies, a specific marker for (early)rheumatoid arthritis. Clin. Applied. Immunol. Rev., 2004, 4, 239-262.
31. Mathsson, L.; Mullazehi, M.; Wick, M. C.; Sjoberg, O.; van Vollenhoven, R.; Klareskog, L.; Ronnelid, J. Antibodies against citrullinated vimentin in rheumatoid arthritis. Arthritis Rheum., 2008, 58(1), 36-45.
32. Uysal, H.; Nandakumar, K. S.; Kessel, C.; Haag, S.; Carlsen, S.; Burkhardt, H.; Holmdahl, R. Antibodies to citrullinated proteins: molecular interactions and arthritogenicity. Immunol. Rev., 2010, 233, 9-33.
33. Koivula, M. K.; Ramberg, J.; Aman, S.; Karjalainen, A.; Hakala, M.; Risteli, J. Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis. Clin. Chem. Lab. Med., 2005, 43(12), 1400-1405.
34. Sebbag, M.; Moinard, N.; Auger, I.; Clavel, C.; Arnaud, J.; Nogueira, L.; Roudier, J.; Serre, G. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur. J. Immunol., 2006, 36(8), 2250-2263.
35. Lundberg, K.; Kinloch, A.; Fisher, B. A.; Wegner, N.; Wait, R.; Charles, P.; Mikuls, T. R.; Venables, P. J. Antibodies to Citrullinated alpha-Enolase Peptide 1 Are Specific for Rheumatoid Arthritis and Cross-React With Bacterial Enolase. Arthritis Rheum., 2008, 58(10), 3009-3019.
36. Pratesi, F.; Tommasi, C.; Anzilotti, C.; Puxeddu, I.; Sardano, E.; Di Colo, G.; Migliorini, P. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. Clin. Exp. Immunol., 2011, 164(3), 337-345.
37. Mydel, P.; Wang, Z. N.; Brisslert, M.; Hellvard, A.; Dahlberg, L. E.; Hazen, S. L.; Bokarewa, M. Carbamylation-Dependent Activation of T Cells: A Novel Mechanism in the Pathogenesis of Autoimmune Arthritis. J. Immunol., 2010, 184(12), 6882-6890.
38. Shi, J.; Knevel, R.; Suwannalai, P.; van der Linden, M. P.; Janssen, G. M. C.; van Veelen, P. A.; Levarht, N. E. W.; van der Helm-van Mil; Cerami, A.; Huizinga, T. W. J.; Toes, R. E. M.; Trouw, L. A. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. P. Natl. Acad. Sci. USA, 2011, 108(42), 17372-17377.
39. Turunen, S.; Koivula, M. K.; Risteli, L.; Risteli, J. Anticitrulline Antibodies Can Be Caused by Homocitrulline-Containing Proteins in Rabbits. Arthritis Rheum., 2010, 62(11), 3345-3352.
40. Perez, M. L.; Gomara, M. J.; Kasi, D.; Alonso, A.; Vinas, O.; Ercilla, G.; Sanmarti, R.; Haro, I. Synthesis of overlapping fibrin citrullinated peptides and their use for diagnosing rheumatoid arthritis. Chem. Biol. Drug Des., 2006, 68(4), 194-200.
41. Perez, M. L.; Gomara, M. J.; Ercilla, G.; Sanmarti, R.; Haro, I. Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis. J Med. Chem., 2007, 50(15), 3573-3584.
42. Sanmarti, R.; Graell, E.; Perez, M. L.; Ercilla, G.; Vinas, O.; Gomez-Puerta, J. A.; Gratacos, J.; Balsa, A.; Gomara, M. J.; Larrosa, M.; Canete, J. D.; Haro, I. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis. Arthritis Res. Ther., 2009, 11(5), R135.
43. Malakoutikhah, M.; Gomara, M. J.; Gomez-Puerta, J. A.; Sanmarti, R.; Haro, I. The Use of Chimeric Vimentin Citrullinated Peptides for the Diagnosis of Rheumatoid Arthritis. J. Med. Chem., 2011, 54(21), 7486-7492.
44. Foong, Y. M.; Fu, J. Q.; Yao, S. Q.; Uttamchandani, M. Current advances in peptide and small molecule microarray technologies. Curr. Opin. Chem. Biol., 2012, 16(1-2), 234-242.
45. Uttamchandani, M.; Yao, S. Q. Peptide microarrays: Next generation biochips for detection, diagnostics and high-throughput screening. Curr. Pharm. Design, 2008, 14(24), 2428-2438.
46. Robinson, W. H.; DiGennaro, C.; Hueber, W.; Haab, B. B.; Kamachi, M.; Dean, E. J.; Fournel, S.; Fong, D.; Genovese, M. C.; de Vegvar, H. E. N.; Skriner, K.; Hirschberg, D. L.; Morris, R. I.; Muller, S.; Pruijn, G. J.; van Venrooij, W. J.; Smolen, J. S.; Brown, P. O.; Steinman, L.; Utz, P. J. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med., 2002, 8(3), 295-301.
47. Chandra, P. E.; Sokolove, J.; Hipp, B. G.; Lindstrom, T. M.; Elder, J. T.; Reveille, J. D.; Eberl, H.; Klause, U.; Robinson, W. H. Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthritis Res. Ther., 2011, 13(3), R102
48. Hecker, M.; Lorenz, P.; Steinbeck, F.; Hong, L.; Riemekasten, G.; Li, Y. X.; Zettl, U. K.; Thiesen, H. J. Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis. Autoimmun. Rev., 2012, 11(3), 180-190.
49. Lea, P.; Keystone, E.; Mudumba, S.; Kahama, A.; Ding, S. F.; Hansen, J.; Azad, A. A.; Wang, S. H.; Weber, D. Advantages of Multiplex Proteomics in Clinical Immunology The Case of Rheumatoid Arthritis: Novel IgXplex (TM) Planar Microarray Diagnosis. Clin. Rev. Allerg. Immu., 2011, 41(1), 20-35.
50. Yu, X. B.; Schneiderhan-Marra, N.; Joos, T. O. Protein Microarrays for Personalized Medicine. Clin. Chem., 2010, 56(3), 376-387.
51. Szodoray, P.; Alex, P. Protein Array Diagnostics for Guiding Therapy in Rheumatoid Arthritis. Mol. Diagn. Ther., 2011, 15(5), 247-254.
52. Hueber, W.; Tomooka, B. H.; Zhao, X. Y.; Kidd, B. A.; Drijfhout, J. W.; Fries, J. F.; van Venrooij, W. J.; Metzger, A. L.; Genovese, M. C.; Robinson, W. H. Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann. Rheum. Dis., 2007, 66(6), 712-719.
53. Hueber, W.; Kidd, B. A.; Tomooka, B. H.; Lee, B. J.; Bruce, B.; Fries, J. F.; Sonderstrup, G.; Monach, P.; Drijfhout, J. W.; van Venrooij, W. J.; Utz, P. J.; Genovese, M. C.; Robinson, W. H. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum., 2005, 52(9), 2645-2655.
54. Sokolove, J.; Bromberg, R.; Deane, K. D.; Lahey, L. J.; Derber, L. A.; Chandra, P. E.; Edison, J. D.; Gilliland, W. R.; Tibshirani, R. J.; Norris, J. M.; Holers, V. M.; Robinson, W. H. Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis. Plos One 2012, 7(5), e35296.
55. Ahn, K. Y.; Kwon, K.; Huh, J.; Kim, G. T.; Lee, E. B.; Park, D.; Lee, J. A sensitive diagnostic assay of rheumatoid arthritis using three-dimensional ZnO nanorod structure. Biosens. Bioelectron., 2011, 28(1), 378-385.
56. Drouvalakis, K. A.; Bangsaruntip, S.; Hueber, W.; Kozar, L. G.; Utz, P. J.; Dai, H. J. Peptide-coated nanotube-based biosensor for the detection of disease-specific autoantibodies in human serum. Biosens. Bioelectron., 2008, 23(10), 1413-1421.
57. Villa, M. D.; Jimenez-Jorquera, C.; Haro, I.; Gomara, M. J.; Sanmarti, R.; Fernandez-Sanchez, C.; Mendoza, E. Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis. Biosens. Bioelectron., 2011, 27(1), 113-118.